Search This Blog

Tuesday, November 7, 2023

Vertex pharmaceuticals incorporated: Barclays raises the target price from USD 399 to USD 408.

 maintains its overweight recommendation

https://www.marketscreener.com/quote/stock/VERTEX-PHARMACEUTICALS-IN-11321/




Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)